{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:55:17Z","timestamp":1794887717495,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Project Plan of Medical Science Research in Hebei Province","award":["20221155"],"award-info":[{"award-number":["20221155"]}]},{"name":"Government-Funded Clinical Medical Outstanding Talent Project","award":["ZF2023102"],"award-info":[{"award-number":["ZF2023102"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170892"],"award-info":[{"award-number":["82170892"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hebei Province Natural Science Foundation Precision Medicine Joint Fund Cultivation Project","award":["H2020206314"],"award-info":[{"award-number":["H2020206314"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-024-05361-z","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T13:08:54Z","timestamp":1734959334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Association between polymorphisms of glucagon-like peptide-1 receptor gene and susceptibility to osteoporosis in Chinese postmenopausal women"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiaoxue","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"issue":"10169","key":"5361_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD. Osteoporosis Lancet. 2019;393(10169):364\u201376. https:\/\/doi.org\/10.1016\/S0140-6736(18)32112-3.","journal-title":"Osteoporosis Lancet"},{"issue":"10","key":"5361_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/medicina57101119","volume":"57","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Giorgino R, Hildebrand F, Spiezia F, Peretti GM, Alessandri-Bonetti M, et al. Fragility Fractures: Risk Factors and Management in the Elderly. Medicina (Kaunas). 2021;57(10):1119. https:\/\/doi.org\/10.3390\/medicina57101119.","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"5361_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11657-018-0549-y","volume":"14","author":"F Yu","year":"2019","unstructured":"Yu F, Xia W. The epidemiology of osteoporosis, associated fragility fractures, and management gap in China. Arch Osteoporos. 2019;14(1):32. https:\/\/doi.org\/10.1007\/s11657-018-0549-y.","journal-title":"Arch Osteoporos"},{"issue":"8","key":"5361_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.21106","volume":"4","author":"L Wang","year":"2021","unstructured":"Wang L, Yu W, Yin X, Cui L, Tang S, Jiang N, et al. Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study. JAMA Netw Open. 2021;4(8): e2121106. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.21106.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"5361_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/17512433.2021.1851192","volume":"14","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Colarossi G, Baroncini A, Eschweiler J, Tingart M, Maffulli N. Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion. Expert Rev Clin Pharmacol. 2021;14(1):105\u201319. https:\/\/doi.org\/10.1080\/17512433.2021.1851192.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"5361_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/bmb\/ldac017","volume":"143","author":"F Migliorini","year":"2022","unstructured":"Migliorini F, Colarossi G, Eschweiler J, Oliva F, Driessen A, Maffulli N. Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis. Br Med Bull. 2022;143(1):46\u201356. https:\/\/doi.org\/10.1093\/bmb\/ldac017.","journal-title":"Br Med Bull"},{"issue":"1","key":"5361_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13018-021-02474-7","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Spiezia F, Tingart M, Maria PG, Riccardo G. Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):318. https:\/\/doi.org\/10.1186\/s13018-021-02474-7.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"5361_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13018-021-02497-0","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Spiezia F, Peretti GM, Tingart M, Giorgino R. Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):351. https:\/\/doi.org\/10.1186\/s13018-021-02497-0.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"5361_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s13018-021-02678-x","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Colarossi G, Eschweiler J, Tingart M, Betsch M. Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis. J Orthop Surg Res. 2021;16(1):533. https:\/\/doi.org\/10.1186\/s13018-021-02678-x.","journal-title":"J Orthop Surg Res"},{"issue":"2","key":"5361_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41574-019-0282-7","volume":"16","author":"TL Yang","year":"2020","unstructured":"Yang TL, Shen H, Liu A, Dong SS, Zhang L, Deng FY, et al. A road map for understanding molecular and genetic determinants of osteoporosis. Nat Rev Endocrinol. 2020;16(2):91\u2013103. https:\/\/doi.org\/10.1038\/s41574-019-0282-7.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"5361_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1210\/edrv.23.3.0464","volume":"23","author":"M Peacock","year":"2002","unstructured":"Peacock M, Turner CH, Econs MJ, Foroud T. Genetics of osteoporosis. Endocr Rev. 2002;23(3):303\u201326. https:\/\/doi.org\/10.1210\/edrv.23.3.0464.","journal-title":"Endocr Rev"},{"key":"5361_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.trsl.2016.10.009","volume":"181","author":"OL Sabik","year":"2017","unstructured":"Sabik OL, Farber CR. Using GWAS to identify novel therapeutic targets for osteoporosis. Transl Res. 2017;181:15\u201326. https:\/\/doi.org\/10.1016\/j.trsl.2016.10.009.","journal-title":"Transl Res"},{"issue":"1","key":"5361_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13018-021-02454-x","volume":"16","author":"G Li","year":"2021","unstructured":"Li G, Gu Z, He Y, Wang C, Duan J. The effect of SOX4 gene 3\u2019UTR polymorphisms on osteoporosis. J Orthop Surg Res. 2021;16(1):321. https:\/\/doi.org\/10.1186\/s13018-021-02454-x.","journal-title":"J Orthop Surg Res"},{"issue":"2","key":"5361_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/genes12020200","volume":"12","author":"S Abdi","year":"2021","unstructured":"Abdi S, Binbaz RA, Mohammed AK, Ansari MGA, Wani K, Amer OE, et al. Association of RANKL and OPG Gene Polymorphism in Arab Women with and without Osteoporosis. Genes (Basel). 2021;12(2):200. https:\/\/doi.org\/10.3390\/genes12020200.","journal-title":"Genes (Basel)"},{"issue":"3","key":"5361_CR15","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.3390\/ijms16035452","volume":"16","author":"V Conti","year":"2015","unstructured":"Conti V, Russomanno G, Corbi G, Toro G, Simeon V, Filippelli W, et al. A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from southern Italy. Int J Mol Sci. 2015;16(3):5452\u201366. https:\/\/doi.org\/10.3390\/ijms16035452.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5361_CR16","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1089\/dna.2018.4397","volume":"37","author":"L Gao","year":"2018","unstructured":"Gao L, Li SL, Li YK. Liraglutide Promotes the Osteogenic Differentiation in MC3T3-E1 Cells via Regulating the Expression of Smad2\/3 Through PI3K\/Akt and Wnt\/\u03b2-Catenin Pathways. DNA Cell Biol. 2018;37(12):1031\u201343. https:\/\/doi.org\/10.1089\/dna.2018.4397.","journal-title":"DNA Cell Biol"},{"key":"5361_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110523","volume":"130","author":"Z Li","year":"2020","unstructured":"Li Z, Li S, Wang N, Xue P, Li Y. Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-\u03baB and MAPK pathways via GLP-1R. Biomed Pharmacother. 2020;130: 110523. https:\/\/doi.org\/10.1016\/j.biopha.2020.110523.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"5361_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.yexcr.2017.09.018","volume":"360","author":"X Wu","year":"2017","unstructured":"Wu X, Li S, Xue P, Li Y. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)\/protein kinase B (AKT), extracellular signal-related kinase (ERK)1\/2, and cAMP\/protein kinase A (PKA) signaling pathways involving \u03b2-catenin. Exp Cell Res. 2017;360(2):281\u201391. https:\/\/doi.org\/10.1016\/j.yexcr.2017.09.018.","journal-title":"Exp Cell Res"},{"issue":"4","key":"5361_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.stemcr.2016.02.002","volume":"6","author":"J Meng","year":"2016","unstructured":"Meng J, Ma X, Wang N, Jia M, Bi L, Wang Y, et al. Activation of GLP-1 Receptor Promotes Bone Marrow Stromal Cell Osteogenic Differentiation through \u03b2-Catenin. Stem Cell Reports. 2016;6(4):579\u201391. https:\/\/doi.org\/10.1016\/j.stemcr.2016.02.002.","journal-title":"Stem Cell Reports"},{"issue":"2","key":"5361_CR20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1210\/en.2007-1292","volume":"149","author":"C Yamada","year":"2008","unstructured":"Yamada C, Yamada Y, Tsukiyama K, Yamada K, Udagawa N, Takahashi N, et al. The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. Endocrinology. 2008;149(2):574\u20139. https:\/\/doi.org\/10.1210\/en.2007-1292.","journal-title":"Endocrinology"},{"issue":"1","key":"5361_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/JOE-13-0146","volume":"219","author":"G Mabilleau","year":"2013","unstructured":"Mabilleau G, Mieczkowska A, Irwin N, Flatt PR, Chappard D. Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor. J Endocrinol. 2013;219(1):59\u201368. https:\/\/doi.org\/10.1530\/JOE-13-0146.","journal-title":"J Endocrinol"},{"issue":"4","key":"5361_CR22","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.21037\/apm-19-396","volume":"9","author":"L Zhang","year":"2020","unstructured":"Zhang L, He J, Sun X, Luo X, Zeng J, He W, Liu X, Feng Bo. Relationship between glucagon-like peptide-1 receptor gene polymorphism and bone mineral density in postmenopausal women in Shanghai. Annals of Palliative Medicine. 2020;9(4):1732\u201341. https:\/\/doi.org\/10.21037\/apm-19-396.","journal-title":"Annals of Palliative Medicine"},{"issue":"18","key":"5361_CR23","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1101\/gad.1449506","volume":"20","author":"SH Ralston","year":"2006","unstructured":"Ralston SH, de Crombrugghe B. Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev. 2006;20(18):2492\u2013506. https:\/\/doi.org\/10.1101\/gad.1449506.","journal-title":"Genes Dev"},{"issue":"1","key":"5361_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13098-022-00963-1","volume":"14","author":"P Luo","year":"2022","unstructured":"Luo P, Fan Y, Xiong Y, Feng H, Yang Z, Zhang C, et al. Genetic variants of the GLP-1R gene affect the susceptibility and glucose metabolism of gestational diabetes mellitus: a two-center nested case-control study. Diabetol Metab Syndr. 2022;14(1):190. https:\/\/doi.org\/10.1186\/s13098-022-00963-1.","journal-title":"Diabetol Metab Syndr"},{"issue":"5","key":"5361_CR25","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00228-021-03249-z","volume":"78","author":"Z Guan","year":"2022","unstructured":"Guan Z, Du Y, Li R, Zhang S, Xu Y, Zhang X, et al. Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study. Eur J Clin Pharmacol. 2022;78(5):793\u20139. https:\/\/doi.org\/10.1007\/s00228-021-03249-z.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"5361_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/nu13020351","volume":"13","author":"J Micha\u0142owska","year":"2021","unstructured":"Micha\u0142owska J, Miller-Kasprzak E, Bogda\u0144ski P. Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective. Nutrients. 2021;13(2):351. https:\/\/doi.org\/10.3390\/nu13020351.","journal-title":"Nutrients"},{"issue":"6","key":"5361_CR27","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2337\/db16-1364","volume":"66","author":"R Sim\u00f3","year":"2017","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C. GLP-1R as a Target for the Treatment of Diabetic Retinopathy: Friend or Foe? Diabetes. 2017;66(6):1453\u201360. https:\/\/doi.org\/10.2337\/db16-1364.","journal-title":"Diabetes"},{"issue":"11","key":"5361_CR28","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1021\/acs.bioconjchem.8b00663","volume":"29","author":"R Shi","year":"2018","unstructured":"Shi R, Nejad MI, Zhang X, Gu LQ, Gates KS. Generation and Single-Molecule Characterization of a Sequence-Selective Covalent Cross-Link Mediated by Mechlorethamine at a C-C Mismatch in Duplex DNA for Discrimination of a Disease-Relevant Single Nucleotide Polymorphism. Bioconjug Chem. 2018;29(11):3810\u20136. https:\/\/doi.org\/10.1021\/acs.bioconjchem.8b00663.","journal-title":"Bioconjug Chem"},{"issue":"3","key":"5361_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41588-018-0332-4","volume":"51","author":"K Suzuki","year":"2019","unstructured":"Suzuki K, Akiyama M, Ishigaki K, Kanai M, Hosoe J, Shojima N, et al. Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population. Nat Genet. 2019;51(3):379\u201386. https:\/\/doi.org\/10.1038\/s41588-018-0332-4.","journal-title":"Nat Genet"},{"issue":"9","key":"5361_CR30","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1089\/dna.2020.5424","volume":"39","author":"W Li","year":"2020","unstructured":"Li W, Li P, Li R, Yu Z, Sun X, Ji G, et al. GLP1R Single-Nucleotide Polymorphisms rs3765467 and rs10305492 Affect \u03b2 Cell Insulin Secretory Capacity and Apoptosis Through GLP-1. DNA Cell Biol. 2020;39(9):1700\u201310. https:\/\/doi.org\/10.1089\/dna.2020.5424.","journal-title":"DNA Cell Biol"},{"key":"5361_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147589","volume":"878","author":"Y Li","year":"2023","unstructured":"Li Y, Yang Z, Ren S, Shen B, Zhang Y, Zong H, et al. Association between GLP-1R gene polymorphism and dyslipidemia in Chinese patients with type 2 diabetes mellitus: A case-control study. Gene. 2023;878: 147589. https:\/\/doi.org\/10.1016\/j.gene.2023.147589.","journal-title":"Gene"},{"key":"5361_CR32","doi-asserted-by":"publisher","first-page":"1054192","DOI":"10.1155\/2018\/1054192","volume":"2018","author":"X Ma","year":"2018","unstructured":"Ma X, Lu R, Gu N, Wei X, Bai G, Zhang J, et al. Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study. J Diabetes Res. 2018;2018:1054192. https:\/\/doi.org\/10.1155\/2018\/1054192.","journal-title":"J Diabetes Res"},{"issue":"4","key":"5361_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2217\/pgs-2018-0159","volume":"20","author":"MJ Yu","year":"2019","unstructured":"Yu MJ, Wang KY, Liu HM, Cao R. GLP1R variant is associated with response to exenatide in overweight Chinese Type 2 diabetes patients. Pharmacogenomics. 2019;20(4):273\u20137. https:\/\/doi.org\/10.2217\/pgs-2018-0159.","journal-title":"Pharmacogenomics"},{"issue":"6","key":"5361_CR34","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00125-021-05402-w","volume":"64","author":"W Rathmann","year":"2021","unstructured":"Rathmann W, Bongaerts B. Pharmacogenetics of novel glucose-lowering drugs. Diabetologia. 2021;64(6):1201\u201312. https:\/\/doi.org\/10.1007\/s00125-021-05402-w.","journal-title":"Diabetologia"},{"issue":"4","key":"5361_CR35","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/ckj\/sfz182","volume":"13","author":"A Terranegra","year":"2020","unstructured":"Terranegra A, Arcidiacono T, Macrina L, Brasacchio C, Pivari F, Mingione A, et al. Glucagon-like peptide-1 receptor and sarcoglycan delta genetic variants can affect cardiovascular risk in chronic kidney disease patients under hemodialysis. Clin Kidney J. 2020;13(4):666\u201373. https:\/\/doi.org\/10.1093\/ckj\/sfz182.","journal-title":"Clin Kidney J"},{"key":"5361_CR36","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.2147\/DMSO.S310069","volume":"14","author":"T Xu","year":"2021","unstructured":"Xu T, Liu M, Liu Q, Wang B, Wang M, Qu M, et al. Associations of TCF7L2 rs11196218 (A\/G) and GLP-1R rs761386 (C\/T) Gene Polymorphisms with Obesity in Chinese Population. Diabetes Metab Syndr Obes. 2021;14:2465\u201372. https:\/\/doi.org\/10.2147\/DMSO.S310069.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"5361_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/176949","volume":"2015","author":"CH Lin","year":"2015","unstructured":"Lin CH, Lee YS, Huang YY, Hsieh SH, Chen ZS, Tsai CN. Polymorphisms of GLP-1 receptor gene and response to GLP-1 analogue in patients with poorly controlled type 2 diabetes. J Diabetes Res. 2015;2015: 176949. https:\/\/doi.org\/10.1155\/2015\/176949.","journal-title":"J Diabetes Res"},{"issue":"9","key":"5361_CR38","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1210\/clinem\/dgac374","volume":"107","author":"EG Dorsey-Trevino","year":"2022","unstructured":"Dorsey-Trevino EG, Kaur V, Mercader JM, Florez JC, Leong A. Association of GLP1R Polymorphisms With the Incretin Response. J Clin Endocrinol Metab. 2022;107(9):2580\u20138. https:\/\/doi.org\/10.1210\/clinem\/dgac374.","journal-title":"J Clin Endocrinol Metab"},{"key":"5361_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.697442","volume":"12","author":"B Xie","year":"2021","unstructured":"Xie B, Chen S, Xu Y, Han W, Hu R, Chen M, et al. The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment. Front Pharmacol. 2021;12: 697442. https:\/\/doi.org\/10.3389\/fphar.2021.697442.","journal-title":"Front Pharmacol"},{"issue":"7","key":"5361_CR40","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/jbmr.1898","volume":"28","author":"X Ma","year":"2013","unstructured":"Ma X, Meng J, Jia M, Bi L, Zhou Y, Wang Y, et al. Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats. J Bone Miner Res. 2013;28(7):1641\u201352. https:\/\/doi.org\/10.1002\/jbmr.1898.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"5361_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/JME-15-0264","volume":"56","author":"Y Feng","year":"2016","unstructured":"Feng Y, Su L, Zhong X, Guohong W, Xiao H, Li Y, et al. Exendin-4 promotes proliferation and differentiation of MC3T3-E1 osteoblasts by MAPKs activation. J Mol Endocrinol. 2016;56(3):189\u201399. https:\/\/doi.org\/10.1530\/JME-15-0264.","journal-title":"J Mol Endocrinol"},{"key":"5361_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.xnsj.2024.100327","volume":"18","author":"A Filley","year":"2024","unstructured":"Filley A, Baldwin A, Ben-Natan AR, Hansen K, Arora A, Xiao A, et al. The influence of osteoporosis on mechanical complications in lumbar fusion surgery: a systematic review. N Am Spine Soc J. 2024;18: 100327. https:\/\/doi.org\/10.1016\/j.xnsj.2024.100327.","journal-title":"N Am Spine Soc J"},{"key":"5361_CR43","doi-asserted-by":"publisher","DOI":"10.12680\/balneo.2023.588","author":"A-A Lupu","year":"2023","unstructured":"Lupu A-A, Oprea D, Obada B, Iliescu DM, Botnarciuc M, Ionescu A-M, Mihailov CI, Iliescu M-G, Caraban BM. Variation of serum serotonin values under specific peloidotherapy in patients with degenerative pathology of the lumbar spine. Balneo and PRM Research Journal. 2023. https:\/\/doi.org\/10.12680\/balneo.2023.588.","journal-title":"Balneo and PRM Research Journal"},{"issue":"12","key":"5361_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295451","volume":"18","author":"C Liu","year":"2023","unstructured":"Liu C, Bao X, Tian Y, Xue P, Wang Y, Li Y. Polymorphisms in the glucagon-like peptide-1 receptor gene and their interactions on the risk of osteoporosis in postmenopausal Chinese women. PLoS ONE. 2023;18(12): e0295451. https:\/\/doi.org\/10.1371\/journal.pone.0295451.","journal-title":"PLoS ONE"},{"issue":"12","key":"5361_CR45","doi-asserted-by":"publisher","first-page":"i19","DOI":"10.1093\/bioinformatics\/btu261","volume":"30","author":"Y Arkin","year":"2014","unstructured":"Arkin Y, Rahmani E, Kleber ME, Laaksonen R, M\u00e4rz W, Halperin E. EPIQ-efficient detection of SNP-SNP epistatic interactions for quantitative traits. Bioinformatics. 2014;30(12):i19-25. https:\/\/doi.org\/10.1093\/bioinformatics\/btu261.","journal-title":"Bioinformatics"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-024-05361-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-024-05361-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-024-05361-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T14:04:47Z","timestamp":1734962687000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-024-05361-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5361"],"URL":"https:\/\/doi.org\/10.1186\/s13018-024-05361-z","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"I certify that this manuscript is a unique submission and is not being considered for publication, in part or in full, with any other source in any medium.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study protocol was approved by the Medical Ethics Committee of the Hebei Medical University Third Hospital [NO.2023\u2013026-1]. The participants were required to provide written informed consent in accordance with the principles outlined in the Declaration of Helsinki prior to their participation in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"869"}}